Surgery Partners, Inc. (SGRY): who owns it and who trades it
As of Nov 16, 2026, SGRY insiders reported 12 open-market sales worth $1.3M and 2 purchases worth $305K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jason Eric Evans (CEO), with $412K. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Surgery Partners
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns SGRY
187 funds and institutions reported SGRY shares worth $2.7B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is Bain Capital Investors LLC with 38.2%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Bain Capital Investors LLC | 49.95M | 38.19% | $839M | No change |
| Jupiter Topco LLC | 13.88M | 10.61% | $233M | – |
| Pentwater Capital Management LP | 11.63M | 8.89% | $195M | -8% |
| UBS Group AG | 8.57M | 6.56% | $144M | -16% |
| BlackRock, Inc. | 6.24M | 4.77% | $105M | +10% |
| King Street Capital Management, L.P. | 6.06M | 4.63% | $102M | -41% |
| T. Rowe Price Investment Management, Inc. | 5.92M | 4.52% | $99.4M | +203% |
| Dimensional Fund Advisors LP | 4.94M | 3.78% | $83.1M | -7% |
| Clearbridge Investments, LLC | 3.82M | 2.92% | $64.2M | -7% |
| Vanguard Portfolio Management LLC | 3.74M | 2.86% | $62.8M | +3% |
| Vanguard Capital Management LLC | 3.51M | 2.68% | $59M | +2% |
| Davidson Kempner Capital Management LP | 3.34M | 2.55% | $56.1M | No change |
| HSBC Holdings PLC | 2.96M | 2.26% | $48.9M | +54% |
| FMR LLC (Fidelity) | 2.15M | 1.64% | $36.1M | -2% |
| State Street Corp | 2.14M | 1.64% | $36M | +10% |
| Geode Capital Management, LLC | 2.12M | 1.62% | $35.6M | +6% |
| Nomura Holdings Inc | 1.53M | 1.17% | $25.6M | +111% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.47M | 1.13% | $24.7M | -7% |
| LMR Partners LLP | 1.36M | 1.04% | $22.9M | +24% |
| Morgan Stanley | 1.23M | 0.94% | $20.7M | +22% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, SGRY insiders reported $305K of open-market purchases and $1.3M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Teresa DeLuca | Director | Purchase | 11,250 | $14.33 | $161K | Form 4 |
| Aug 18, 2026 | Teresa DeLuca | Director | Purchase | 10,000 | $14.35 | $144K | Form 4 |
| Mar 16, 2026 | David T Doherty | CFO | Sale | 8,867 | $12.50 | $111K | Form 4 |
| Mar 16, 2026 | Jason Eric Evans | CEO | Sale | 20,400 | $12.47 | $254K | Form 4 |
| Mar 13, 2026 | Danielle Burkhalter | Chief Human Resources Of | Sale | 3,469 | $12.83 | $44.5K | Form 4 |
| Mar 13, 2026 | Marissa Brittenham | Chief Strategy Officer | Sale | 3,657 | $12.54 | $45.9K | Form 4 |
| Mar 12, 2026 | Jennifer Baldock | Chief Admin & Dev Office | Sale | 5,798 | $13.17 | $76.4K | Form 4 |
| Mar 6, 2026 | Jason Eric Evans | CEO | Sale | 11,462 | $13.79 | $158K | Form 4 |
| Mar 6, 2026 | David T Doherty | CFO | Sale | 14,574 | $13.84 | $202K | Form 4 |
| Mar 6, 2026 | Jennifer Baldock | Chief Admin & Dev Office | Sale | 10,082 | $13.70 | $138K | Form 4 |
| Mar 6, 2026 | Danielle Burkhalter | Chief Human Resources Of | Sale | 7,736 | $13.60 | $105K | Form 4 |
| Mar 6, 2026 | William Trenton Webb | President | Sale | 272 | $13.93 | $3.8K | Form 4 |
| Mar 6, 2026 | Marissa Brittenham | Chief Strategy Officer | Sale | 8,785 | $13.70 | $120K | Form 4 |
| Mar 5, 2026 | William Trenton Webb | President | Sale | 1,794 | $13.86 | $24.9K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jason Eric Evans | Chief Executive Officer | – | $412K | Mar 16, 2026 |
| David T Doherty | Chief Financial Officer | – | $313K | Mar 16, 2026 |
| Teresa DeLuca | Director | $305K | – | Aug 18, 2026 |
| Jennifer Baldock | Chief Admin & Dev Officer | – | $214K | Mar 12, 2026 |
| Marissa Brittenham | Chief Strategy Officer | – | $166K | Mar 13, 2026 |
| Danielle Burkhalter | Chief Human Resources Officer | – | $150K | Mar 13, 2026 |
| William Trenton Webb | American Group President | – | $28.7K | Mar 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SGRY short interest
Moderate short interest. 6.8% of SGRY shares are sold short: about 1 share in 15. Over the last 12 reports the number of shares short went down 38%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 8.95M SGRY shares were sold short, 6.8% of the shares outstanding, down 37.5% from the report before. At the average daily volume of 8.51M shares, buying them all back would take about 1.1 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 8.95M | 6.84% | -38% | 8.51M | 1.1 |
| Oct 15, 2026 | 14.33M | 10.95% | -0% | 1.39M | 10.3 |
| Sep 30, 2026 | 14.35M | 10.96% | +8% | 2.68M | 5.3 |
| Sep 15, 2026 | 13.29M | 10.15% | +3% | 2.09M | 6.4 |
| Aug 31, 2026 | 12.95M | 9.90% | +2% | 2.77M | 4.7 |
| Aug 14, 2026 | 12.65M | 9.66% | -7% | 2.10M | 6.0 |
| Jul 31, 2026 | 13.54M | 10.35% | -9% | 1.52M | 8.9 |
| Jul 15, 2026 | 14.80M | 11.32% | -2% | 1.30M | 11.4 |
| Jun 30, 2026 | 15.13M | 11.56% | +6% | 1.45M | 10.4 |
| Jun 15, 2026 | 14.27M | 10.91% | +4% | 1.33M | 10.8 |
| May 29, 2026 | 13.72M | 10.49% | -5% | 1.18M | 11.6 |
| May 15, 2026 | 14.49M | 11.08% | -8% | 2.21M | 6.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Surgery Partners company events
Surgery Partners filed 12 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 9, 2026.
- Nov 9, 2026ResultsReleased financial results. Filing
- Nov 9, 2026AgreementSurgery Partners, Inc., a Delaware corporation, entered into Amendment No. 1 to Agreement and Plan of Merger with Spyglass Topco, LLC, a Delaware limited liability company, Spyglass Merger Subsidiary, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent, and, solely for the limited… Filing
- Oct 26, 2026AgreementSurgery Partners, Inc. entered into an Agreement and Plan of Merger with Spyglass Topco, LLC, a Delaware limited liability company, Spyglass Merger Subsidiary, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent, and, solely for the limited purposes set forth therein, Bon Secours… Filing
- Sep 17, 2026DealSurgery Partners, Inc., through certain of its subsi diaries, completed the disposition of Moun tain View Hospital, LLC and Idaho Falls Community Hospital, LLC, to Intermountain Health. Filing
- Aug 10, 2026ResultsReleased financial results. Filing
- Jul 24, 2026AgreementA subsidiary of Surgery Partners, Inc., the Company and Intermountain Health placed into escrow pursuant to a binding agreement their respective signature pages to two Securities Purchase Agreements, pursuant to which Buyer would agree to acquire from Seller its ownership interests in Mountain View… Filing
- Jun 5, 2026VoteReported shareholder vote results. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Mar 2, 2026ResultsReleased financial results. Filing
- Dec 16, 2025AgreementSurgery Center Holdings, Inc., a wholly-owned subsidiary of Surgery Partners, Inc., issued an additional $425.0 million of 7.250% Senior Notes due 2032. Filing
- Dec 12, 2025AnnouncementSurgery Center Holdings, Inc., entered into a purchase agreement with Barclays Capital Inc. as representative of certain initial purchasers, relating to the issuance and sale of $425.0 million in of the Issuer’s 7.250% senior unsecured notes due 2032. Filing
- Dec 11, 2025AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Surgery Partners financials
Famous investors that hold SGRY
4 of the 50 well-known investors we track reported holding SGRY in their latest 13F filing. The largest position is Larry Robbins's, worth $90.4M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Larry Robbins · Glenview Capital Management | Q3 2026 | 6.52M | $90.4M | 1.6% | New |
| Howard Marks · Oaktree Capital Management | Q2 2026 | 862,588 | $14.5M | 0.4% | New |
| Ken Griffin · Citadel Advisors | Q3 2026 | 550,377 | $7.6M | 0.0% | +89% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 273,208 | $3.8M | 0.0% | +77% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named SGRY in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Pentwater Capital Management LP | 13G/A | 8.3% |
| Nov 16, 2026 | Pentwater Capital Management LP | 13G/A | 8.3% |
| Nov 6, 2026 | JANUS HENDERSON GROUP Ltd. | 13G/A | 4.9% |
| Nov 6, 2026 | JANUS HENDERSON GROUP Ltd. | 13G/A | 4.9% |
| Oct 26, 2026 | BCPE Seminole Holdings LP | 13D/A | 8.2% |
| Oct 26, 2026 | BCPE Seminole Holdings LP | 13D/A | 8.2% |
| Oct 13, 2026 | GLENVIEW CAPITAL MANAGEMENT, LLC | 13G | 5.4% |
| Oct 13, 2026 | GLENVIEW CAPITAL MANAGEMENT, LLC | 13G | 5.4% |
Questions about Surgery Partners, Inc. (SGRY) stock
Who owns the most SGRY stock?
The largest reported owner of Surgery Partners, Inc. (SGRY) is Bain Capital Investors LLC, with 38.2% of the company. In total, 187 funds and institutions reported holding SGRY at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are SGRY insiders buying or selling?
In the last 12 months, SGRY insiders reported 2 open-market purchases worth $305K and 12 sales worth $1.3M. The latest trade was on Aug 18, 2026. See every trade.
What is the short interest in SGRY?
As of Oct 30, 2026, 8.95M SGRY shares were sold short, 6.8% of the shares outstanding, down 37.5% from the report before. At the average daily volume of 8.51M shares, buying them all back would take about 1.1 trading days (days to cover). See the history.
Which famous investors hold SGRY?
4 of the 50 well-known investors we track reported SGRY in their latest 13F filing, including Larry Robbins, Howard Marks, Ken Griffin. The largest position is worth $90.4M. See all holders.
Executive pay
Surgery Partners's chief executive was paid a total of $6.1M for the year ended Dec 31, 2025, down 6% from $6.5M the year before. In the last 12 months, Surgery Partners's executives and directors bought $305K of stock on the open market and sold $1.3M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.